Miglustat HCl (N-Butyldeoxynojirimycin)
Miglustat HCl (N-Butyldeoxynojirimycin) is a small molecule which can act as an a-Glucosidase inhibitor. It is provided as a powder.
This product acts on the following target types: Glycosidase.
This product acts on the following biochemical pathways: Carbohydrate metabolism, Sphingolipid metabolism.
This product may be of interest in the following research areas and diseases: Neuroscience.
This product may act as a Coronavirus inhibitor: Inhibits galactosidase alpha (GLA), which interacts with SARS-CoV-2 Nsp14; analog of IHVR-19029, and antiviral in clinical trials.
Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
This product acts on the following target types: Glycosidase.
This product acts on the following biochemical pathways: Carbohydrate metabolism, Sphingolipid metabolism.
This product may be of interest in the following research areas and diseases: Neuroscience.
This product may act as a Coronavirus inhibitor: Inhibits galactosidase alpha (GLA), which interacts with SARS-CoV-2 Nsp14; analog of IHVR-19029, and antiviral in clinical trials.
Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx282650-25MG |
| Pricing | 25 mg USD $464.0 |
| Availability | Shipped within 5-10 working days. |
| Dry Ice | No |
| Note |
|
| CAS Number | 210110-90-0 |